Literature DB >> 21095621

Vital exhaustion, depressive symptoms and serum triglyceride levels in high-risk middle-aged men.

Cornel Victor Igna1, Juhani Julkunen, Hannu Vanhanen.   

Abstract

The role of elevated serum triglyceride level as a risk factor of coronary artery disease is well established. Previous results have also indicated that depression or depressive symptoms and vital exhaustion correlate with triglyceride levels. The aim of this study was to investigate the associations of depressive symptoms, vital exhaustion, and health behavior with serum triglyceride levels. The study sample comprised 444 high-risk middle-aged men. Participants completed self-report questionnaires before laboratory tests. Triglyceride concentrations were measured by the enzymatic method. Vital exhaustion and depression were associated with unhealthy lifestyles and triglycerides. Vital exhaustion and depression were closely correlated constructs with comparable relations with known coronary artery disease risk factors. When comparing vital exhaustion (VE) to Beck Depression Inventory (BDI), however, the first one had a stronger correlation with triglycerides (TG), and also, path analyses showed a direct link from vital exhaustion to body mass index but not from depression. Both vital exhaustion and depression are related to triglyceride levels. The relations are partly mediated by unfavorable lifestyles. Although vital exhaustion is not so commonly assessed as depression, results of this study support the importance of vital exhaustion as a health-related psychological risk factor.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21095621     DOI: 10.1016/j.psychres.2010.10.016

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  Clinical and socio-demographic predictors of postoperative vital exhaustion in patients after cardiac surgery.

Authors:  Pamela S Miller; Lorraine S Evangelista; Joyce Newman Giger; Kathleen Dracup; Lynn V Doering
Journal:  Heart Lung       Date:  2013 Mar-Apr       Impact factor: 2.210

2.  Lipid Profiles at Birth Predict Teacher-Rated Child Emotional and Social Development 5 Years Later.

Authors:  Erika M Manczak; Ian H Gotlib
Journal:  Psychol Sci       Date:  2019-11-11

3.  Symptom-level modelling unravels the shared genetic architecture of anxiety and depression.

Authors:  Jackson G Thorp; Adrian I Campos; Andrew D Grotzinger; Zachary F Gerring; Jiyuan An; Jue-Sheng Ong; Wei Wang; Suyash Shringarpure; Enda M Byrne; Stuart MacGregor; Nicholas G Martin; Sarah E Medland; Christel M Middeldorp; Eske M Derks
Journal:  Nat Hum Behav       Date:  2021-04-15

4.  Depression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome.

Authors:  A V Lemche; O S Chaban; E Lemche
Journal:  J Endocrinol Invest       Date:  2016-12-23       Impact factor: 4.256

5.  Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic Apoptosis.

Authors:  Zhan Zhao; Ling Zhang; Xu-Dong Guo; Lu-Lu Cao; Teng-Fei Xue; Xiao-Jie Zhao; Dan-Dan Yang; Jin Yang; Juan Ji; Ji-Ye Huang; Xiu-Lan Sun
Journal:  Front Mol Neurosci       Date:  2017-09-14       Impact factor: 5.639

6.  Association of Vital Exhaustion with Risk Factors for Cardiovascular Diseases, Quality of Life and Lifestyle in 41-44-Year-Old Muscovite Men.

Authors:  Marina B Kotova; Vyacheslav B Rozanov; Anton R Kiselev; Sergey A Maksimov; Oxana M Drapkina
Journal:  Int J Environ Res Public Health       Date:  2021-09-14       Impact factor: 3.390

7.  Exhaustion, immuno-inflammation, and pathogen burden after cardiac surgery: an exploratory study.

Authors:  Pamela S Miller; Lorraine S Evangelista; Joyce Newman Giger; Otoniel Martinez-Maza; Teresita Corvera-Tindel; Larry Magpantay; Guadalupe Pena; Lynn V Doering
Journal:  Eur J Cardiovasc Nurs       Date:  2013-03-22       Impact factor: 3.908

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.